Artigo Revisado por pares

Cyclosporine Delays but does not Prevent Clinical Onset in Glucose Intolerant Pre-type 1 Diabetic Children

1996; Elsevier BV; Volume: 9; Issue: 6 Linguagem: Inglês

10.1006/jaut.1996.0096

ISSN

1095-9157

Autores

Jean‐Claude Carel, Christian Boîtard, George S. Eisenbarth, Jean-François Bach, Pierre-François Bougnères,

Tópico(s)

Diabetes Treatment and Management

Resumo

We conducted a pilot study of immunosuppression with low dose cyclosporine in first degree relatives of diabetic patients with immunologic and metabolic criteria for preclinical diabetes: islet cell antibodies (ICA) ≥20 Juvenile Diabetes Foundation (JDF) units, first phase insulin response 34±8 months,P<0.001 vs the control group; Mann–Whitney test). First phase insulin response increased to normal values in two patients. These results suggest that reversible functional impairment, in association with β-cell destruction, contributes to the failure of insulin secretion in preclinical type 1 diabetes.

Referência(s)